Hyperbaric oxygen therapy (HBOT) is one of the safest medical treatments available and more than 30,000 research studies support its use for a wide array of health conditions HBOT involves breathing oxygen in a pressurized chamber. HBOT can be effective in treating resistant infections such as Lyme disease and mold, brain injuries and concussions, cognitive decline, non-healing wounds and inflammatory conditions ranging from arthritis to ulcerative colitis.
HBOT is antimicrobial
The hyperbaric environment is particularly safe for people with concerns about their health and Covid-19. HBOT is a powerful antimicrobial, killing bacteria, viruses, mold, and disrupting biofilms. In the case of Covid-19, hyperbaric conditions destroy the virus envelope, causing it to disintegrate.1
Research being conducted in a number of hospitals around the world is demonstrating that HBOT may be the most effective treatment available for acute SARS/Covid-19 infections2. It addresses both the low oxygen levels that result from lung inflammation, preventing organ failure, and the cytokine storm that is another primary danger from Covid-193
Preventing the spread of Covid-19
At Hyperbaric Vermont we maintain sanitizing treatment chambers, mask wearing at all times, and each person is in their own chamber with their own oxygen mask. If you have a health concern you would like to address and do not have symptoms of Covid -19 we encourage you to call and schedule an Intake with our physician for a medical review to see if hyperbaric treatment is appropriate.
This is the perfect time to commit to your own good health.
1 Hyperbaric oxygen therapy (HBOT) increases the production of ROIs throughout the body, leaving no safe harbor for the virus to hide outside the genome. Moreover, it consistently has been shown that a peroxidized viral envelope breaches, and a breached viral envelope causes viral disintegration.
HIV: Reactive oxygen species, enveloped viruses and hyperbaric oxygen
Medical Hypotheses 55(3):232-8
2 Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series https://aawconline.memberclicks.net/assets/docs/COVID-19/2020_Covid_Webinars/JoWC_2020_29_5_Serena_4pp%20Web_Lic.pdf
3 COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?
Antonio De Maio1,2,3 & Lawrence E. Hightower4
A small study from China has shown excellent potential for its use in the treatment of COVID-19 patients (https://drive.google.com/file/d/ 1pjtuT44daBvc8LubVYcR064PLpgIjiFY/view). In this study, five critically ill patients with COVID-19 and signs of hypoxia were subjected to HBOT. After two treatments, a dramatic improvement in the clinical condition of the patients was observed with an increase in blood oxygen saturation level and reduced lung inflammation, as observed by CT scans. There were no concerns about viral contamination and the spread of the disease to medical attendants.